A retrospective case-control study comparing 2 opioid risk mitigation tools in noncritical, nonsurgical hospitalized patients

The results imply PRODIGY is more sensitive than MOSS in identifying noncritical, nonsurgical hospitalized patients at risk for OIRD.

Authors

Institutions

Publication Details

Journal
American Journal of Health-System Pharmacy
Published
2025-11-07
DOI
https://doi.org/10.1093/ajhp/zxaf307
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A retrospective case-control study comparing 2 opioid risk mitigation tools in noncritical, nonsurgical hospitalized patients

Paul Hughes, Kimm M Grafenreed-Freeman, Reem M Ghandour
American Journal of Health-System Pharmacy
Opioid Use Disorder Treatment
article

A retrospective case-control study comparing 2 opioid risk mitigation tools in noncritical, nonsurgical hospitalized patients

Paul Hughes, Kimm M Grafenreed-Freeman, Reem M Ghandour
article en

Abstract

The results imply PRODIGY is more sensitive than MOSS in identifying noncritical, nonsurgical hospitalized patients at risk for OIRD.

American Journal of Health-System Pharmacy
WellStar Health System (US), Emory University (US), Northwest Behavioral Medicine (US)
Openalex Percentile: Top 56%
Opioid Use Disorder Treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.